Policy Positions2020-10-02T14:21:56+00:00
  • Green Band


International Pricing Schemes Will Increase Cost and Adversely Impact Patients

As discussed above, the Infusion Providers Alliance opposes changes to the “buy-and-bill” model that puts patients at risk by unnecessarily increasing the complexity of the supply chain, creating problems with timely access and drug wastage due to changes in therapy regimen and potentially polluting the chain of custody of individual medications for patients.

Categories: Resources|
Go to Top